Previously, Zhang et al. reported that CDCA2 expression could be distinctly upregulated by prostate cancer and its overexpression restrains apoptosis and induces cell proliferation in prostatic cancer and is straightforward adjusted by the HIF-1 alpha pathway [10]. Here, CDCA2 is linked to prostate cancer.